By using this site, you are consenting to our use of cookies. To find out more visit our privacy policy.
American Academy of Neurology and American Association of Neuromuscular & Electrodiagnostic Medicine: Evidence-Based Guideline Summary Evaluation, Diagnosis, and Management of Congenital Muscular Dystrophy
Overview
The objective of the guideline is to delineate optimal diagnostic and therapeutic approaches to congenital muscular dystrophy (CMD) through a systematic review and analysis of available literature.
Members Only Content
Join APTA to get unlimited access to content including evidence-based research, guidance on payment changes, and other resources to help you thrive. Learn more about membership benefits.
Already a member? Log in
Date: March 31, 2015
Contact: practice@apta.org
Content Type: CPG
Kang PB, Morrison L, Iannoccone ST, et al; American Academy of Neurology, American Association of Neuromuscular and Electrodiagnostic Medicine
You Might Also Like...
CPG
Respiratory Management of Patients With Neuromuscular WeaknessMar 13, 2023
This joint guideline by the American College of Chest Physicians and Canadian Thoracic Society covers the prevention of acute exacerbations experienced
CPG
American Academy of Neurology and American Association of Neuromuscular & Electrodiagnostic Medicine: Evidence-Based Guideline Summary Evaluation, Diagnosis, and Management of Fascioscapulohumeral Muscular DystrophyJul 28, 2015
Recommendations for the evaluation, diagnosis, prognostication, and treatment of facioscapulohumeral muscular dystrophy (FSHD) from a systematic review
CPG
American Academy of Neurology and American Association of Neuromuscular & Electrodiagnostic Medicine: Evidence-Based Guideline Summary Diagnosis and Treatment of Limb-Girdle and Distal DystrophiesOct 14, 2014
Offers potential solutions to challenging coverage scenarios that result from incomplete or conflicting evidence on limb-girdle and distal dystrophies